Role of Conserved Tyrosine 343 in Intramolecular Electron Transfer in Human Sulfite Oxidase*

Changjian FengDagger , Heather L. Wilson§, John K. Hurley, James T. Hazzard, Gordon Tollin||, K. V. Rajagopalan§**, and John H. EnemarkDagger DaggerDagger

From the Dagger  Department of Chemistry, University of Arizona, Tucson, Arizona 85721, the § Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, and the  Department of Biochemistry and Molecular Biophysics, University of Arizona, Tucson, Arizona 85721

Received for publication, October 9, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Tyrosine 343 in human sulfite oxidase (SO) is conserved in all SOs sequenced to date. Intramolecular electron transfer (IET) rates between reduced heme (FeII) and oxidized molybdenum (MoVI) in the recombinant wild-type and Y343F human SO were measured for the first time by flash photolysis. The IET rate in wild-type human SO at pH 7.4 is about 37% of that in chicken SO with a similar decrease in kcat. Steady-state kinetic analysis of the Y343F mutant showed an increase in Kmsulfite and a decrease in kcat resulting in a 23-fold attenuation in the specificity constant kcat/Kmsulfite at the optimum pH value of 8.25. This indicates that Tyr-343 is involved in the binding of the substrate and catalysis within the molybdenum active site. Furthermore, the IET rate constant in the mutant at pH 6.0 is only about one-tenth that of the wild-type enzyme, suggesting that the OH group of Tyr-343 is vital for efficient IET in SO. The pH dependences of IET rate constants in the wild-type and mutant SO are consistent with the previously proposed coupled electron-proton transfer mechanism.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In vertebrates the molybdenum cofactor-containing enzyme sulfite oxidase (SO,1 EC 1.8.3.1) catalyzes the oxidation of sulfite to sulfate with the reduction of two equivalents of ferricytochrome c (Equation 1) (1, 2), according to the following equation.
<UP>SO</UP><SUP><UP>2−</UP></SUP><SUB><UP>3</UP></SUB>+<UP>H<SUB>2</SUB>O</UP>+2(<UP>cyt</UP> c)<SUB><UP>ox</UP></SUB> → <UP>SO</UP><SUP><UP>2−</UP></SUP><SUB><UP>4</UP></SUB>+2(<UP>cyt</UP> c)<SUB><UP>red</UP></SUB>+<UP>2H<SUP>+</SUP></UP> (Eq. 1)
This is the terminal reaction in the oxidative degradation of sulfur-containing compounds and is physiologically essential. The absence of SO activity in humans is characterized by dislocation of ocular lenses, mental retardation, and in severe cases, attenuated growth of the brain and early death. These severe neurological symptoms result from the inability to properly produce the molybdenum cofactor and also from point mutations in the SO protein itself (3).

The x-ray crystal structure of the dimeric chicken liver SO has recently been reported (4). Each subunit consists of an N-terminal b5-type cytochrome domain and two larger segments that constitute the central molybdenum binding and C-terminal interface domains. The molybdenum center in SO has square pyramidal coordination geometry. Solvent access to the deeply buried active site is via a channel that opens onto the equatorial Mo-O group. As expected for binding an anionic substrate, the sulfite-binding pocket is very positively charged and consists of three arginines (Arg-138, Arg-190, and Arg-450), Trp-204, and Tyr-322. Tyr-322 is also in close proximity to the molybdenum coordination sphere (Fig. 1A).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1.   A, the substrate binding site in chicken SO (4). Water molecules are depicted as solid black circles. Dotted lines indicate selected hydrogen bonds. B, a possible CEPT mechanism in which Tyr-322 in chicken SO (the equivalent of Tyr-343 in human SO) acts as an intermediary proton shuttle (adapted from Ref. 10).

In the generally accepted catalytic cycle (Fig. 2, Refs. 5-9), the MoVI center of the fully oxidized SO reacts with sulfite to produce sulfate. The two-electron-reduced SO, which is in the MoIV/FeIII state, undergoes intramolecular electron transfer (IET) to generate the MoV/FeII state that can be detected by electron paramagnetic resonance (EPR) spectroscopy. One-electron transfer to exogenous cyt cox, leaving the enzyme in the one-electron-reduced state MoV/FeIII, accomplishes re-oxidation of the FeII center. A second Mo right-arrow Fe IET step (giving MoVIFeII), followed by reduction of a second equivalent of cyt cox, returns the enzyme to the fully oxidized resting state. We have previously shown that exogenous flavin radicals generated in situ with a laser pulse will rapidly reduce the heme center of SO by one electron (Fig. 2) and have used this unique technique to investigate IET between the molybdenum and iron centers as a function of pH values (10-12). Note that this process corresponds to the second IET step noted above. Combining this kinetic information with the crystal structure (4) and the pulsed EPR results (13-17) for the MoV form of the two-electron-reduced state of SO has led to a plausible proposal for a coupled electron-proton transfer (CEPT) reaction at the molybdenum center (18) as shown in Scheme 1.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   Postulated oxidation state changes occurring at the molybdenum and iron centers of SO during the catalytic oxidation of sulfite and the concomitant reduction of cyt c. The one-electron reduction indicated by a dashed arrow connecting MoVIFeIII and MoVIFeII can be initiated with a laser pulse in a solution containing dRF and a sacrificial electron donor (semicarbazide in this study).


View larger version (15K):
[in this window]
[in a new window]
 
Scheme 1.   Proposed CEPT mechanism for IET in SO (adapted from Ref. 10).

In the crystal structure of chicken SO (4), Tyr-322 is within hydrogen-bonding distance of the equatorial Mo-O group, is also accessible to water molecules (Fig. 1A), and was proposed to serve as a proton shuttle between Mo-O and OH- or H2O (10). Fig. 1B gives a detailed schematic view of part of a possible CEPT mechanism in which Tyr-322 acts as an intermediary proton shuttle. A water molecule bound to the molybdenum active site pocket is poised to donate a proton to the equatorial MoVI = O group during reduction to MoV; for the reverse process an OH- anion in the pocket accepts a proton from MoV-OH. Competing hydrogen-bonding interactions of the Mo-OH moiety with Tyr-322 and with the anion occupying the active site may also be responsible for the well known equilibrium between two EPR-distinct forms of SO observed for the sulfite-reduced enzyme (15). This tyrosine residue is conserved in all SOs from animals (6), plants (19), and bacteria (20). The mutation of this conserved tyrosine should provide direct evidence for its role in IET, and this is the goal of the present study.

The most extensively studied examples of SO are from rat, human, and chicken livers, and all three enzymes show a very high degree of sequence similarity with 68% sequence identity between human and chicken SO (21-23). The close similarity of the pulsed EPR spectra for native chicken and human SO indicates that the structures of their molybdenum centers are essentially identical (13, 14). Native SO has been purified from bovine, chicken, rat, and human livers. Rat (22, 24) and human (25-27) SO have been successfully cloned and expressed in active forms. Due to the intricacies of assembling and inserting the molybdenum center into the overexpressed apoenzyme, it is extraordinarily difficult to develop suitable expression systems for recombinant SO having high levels of enzyme activity. Expression of these proteins in Escherichia coli makes it possible to use site-directed mutagenesis to incisively probe the roles of specific residues in catalysis (25, 26, 28). This is particularly true for human SO where, in addition to structural studies, site-directed mutagenesis can be expected to critically evaluate the involvement of specific amino acid residues in pathological human SO deficiency. In the present experiments we explore the role of the conserved Tyr-343 in human SO (the equivalent of Tyr-322 in chicken SO) by comparative steady-state kinetic and flash-induced IET studies of the wild-type and the Y343F mutant.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Site-directed Mutagenesis-- The Y343F mutation was introduced into pTG918 (24) using the Transformer Site-directed Mutagenesis kit (Clontech) with the mutagenic primer Y343F (GGCGGGATTTCAAAGGCTTCTC). Mutations were verified by sequence analysis performed at the Duke University DNA Analysis facility.

Expression and Purification of Wild-type and Y343F Human SO-- Both recombinant wild-type and Y343F human SO were expressed and purified as previously described (24, 25) with the following modifications. After the phenyl-Sepharose column, fractions exhibiting an A414/A280 ratio greater than 0.89 were pooled and further purified using the gel filtration column Zorbax GF-250 (Agilent Technologies). Fractions exhibiting an A414/A280 ratio of 0.96 or greater were then pooled and used in the experiments described in this study. The molybdenum content of purified SO proteins was determined using a Perkin-Elmer Zeeman/3030 atomic absorption spectrometer as previously described (25, 29). Enzyme concentrations were determined by using molar extinction coefficients of 99,900 and 113,000 M-1 cm-1 at 413 nm for the oxidized chicken and human SO, respectively.

Laser Flash Photolysis-- Laser flash photolysis experiments were performed anaerobically on 0.50-ml solutions containing ~90 µM 5-deazariboflavin (dRF) and 0.5 mM freshly prepared semicarbazide as a sacrificial reductant. The methodology used has been described previously (10, 30). The published method (30) was used for studying the effect of solution viscosity on IET in human SO. The laser apparatus and associated visible absorbance detection system have been extensively described (31) as has the basic photochemical process by which 5-deazariboflavin semiquinone (dRFH·) is generated by reaction between triplet state dRF and the sacrificial reductant and used to reduce redox-active proteins (32-34). Further details concerning the photochemical process, which are of particular relevance to the SO system, are presented below. Non-linear least-squares fitting of experimental data at 513 nm was generally performed using an implementation of the Levenberg-Marquart algorithm (10), provided as part of the Microcal Origin (version 7.0; Northampton, MA) software package for data processing and display. Transient absorbance changes at 555 nm were analyzed using the computer fitting procedure SIFIT, obtained from OLIS Inc. (Jefferson, GA).

Steady-state Kinetics-- Steady-state enzyme kinetic studies were performed aerobically in a Varian Cary-300 spectrophotometer. Initial velocities were determined by following the reduction of a freshly prepared oxidized cytochrome c (type VI, Sigma) solution at 550 nm, using an extinction coefficient change of 19,630 M-1 cm-1 (35). SO was routinely assayed at 25 °C in 100 mM Tris buffer and adjusted to pH 8.0 with acetic acid. The steady-state kinetic pH profile study was conducted using a saturating concentration of cytochrome c, 15 µM (7-fold greater than Km), and varying the concentration of sulfite between 2 and 496 µM. The buffers used over the pH range 6.0-8.7 were 100 mM Bis-Tris (pH 6.0-6.5), Bis-Tris propane (pH 6.7-7.5), and Tris (pH 7.5-8.7) adjusted to the appropriate pH with acetic acid to minimize the possibility of anion inhibition (36). The buffer used over the pH range 8.7-9.5 was 100 mM glycine adjusted to the appropriate pH with NaOH. The total concentrations of the wild-type and Y343F human SO are 2.6 × 10-10 M and 4.3 × 10-10 - 1.1 × 10-9 M, respectively.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Photochemical Reduction of Human SO by Deazariboflavin Semiquinone-- The photochemical reduction of the FeIII heme moiety of human SO was monitored by laser flash photolysis-induced transient absorbance changes. The flash-induced difference spectrum is shown in Fig. 3. The peak wavelengths (555 and 523 nm) and isosbestic points (513, 533, 545, and 565 nm) observed in the flash-induced difference spectra are identical to those observed in the steady-state reduced minus oxidized difference spectrum for heme reduction (inset of Fig. 3). These spectra confirm that the transient absorbance changes observed at 555 nm are directly related to reduction and re-oxidation of the b-type heme prosthetic group (11). No detectable spectral contribution from the molybdenum cofactor was observed. It is important to note that human SO (wild-type and Y343F mutant) has photochemical reduction properties that are similar to the native chicken SO.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   Flash-induced difference spectrum of wild-type human SO obtained 20 ms after the laser flash. The dotted lines with peaks at 555 and 523 nm were obtained by a Gaussian fit to the data. Anaerobic solutions contained 10 µM SO, 0.5 mM semicarbazide hydrochloride and ~90 µM dRF. Within the resolution of the experiment, the flash-induced difference spectrum is identical to that obtained by steady-state reduction (inset). Difference spectra obtained at longer times were similar in appearance indicating that no further reduction occurred.

Fig. 4, A and B show typical transient kinetic traces of absorbance changes at 555 nm upon laser flash photoexcitation of a solution containing oxidized wild-type human SO (Fig. 4A) or native chicken SO (Fig. 4B), dRF, and semicarbazide. The kinetic behavior can be fully described in terms of the minimal set of reactions shown in Equations 2-5. dRFH· is generated by the laser pulse in the presence of the sacrificial electron donor semicarbazide (AH2) (Equation 3). The initial positive deflection of absorbance from zero in Fig. 4 is due to net reduction of the SO heme center to the FeII form (Equation 4), which has an absorbance maximum at 555 nm (Fig. 3). The slow decrease in absorbance that follows the initial rapid increase is due to the net IET from FeII to MoVI, which establishes an equilibrium between the MoVIFeII and MoVFeIII forms of SO (Equation 5). The kinetics of this latter process is independent of the concentrations of human and chicken SO, indicating that it is due to a first-order IET process, which is the reaction that is of particular interest to us in this study.
<UP>dRF</UP> <LIM><OP><ARROW>→</ARROW></OP><UL><UP>h&ngr;</UP></UL></LIM> <SUP><UP>1</UP></SUP><UP>dRF</UP> <LIM><OP><ARROW>→</ARROW></OP></LIM> <SUP><UP>3</UP></SUP><UP>dRF</UP> (Eq. 2)

<SUP><UP>3</UP></SUP><UP>dRF</UP>+<UP>AH<SUB>2</SUB></UP> <LIM><OP><ARROW>→</ARROW></OP></LIM> <UP>dRFH<SUP>⋅</SUP></UP>+<UP>AH<SUP>⋅</SUP></UP> (Eq. 3)

<UP>dRFH<SUP>⋅</SUP></UP>+<UP>Mo<SUP>VI</SUP>Fe<SUP>III</SUP></UP> <LIM><OP><ARROW>→</ARROW></OP><UL>k<SUB>1</SUB></UL></LIM> <UP>dRF</UP>+<UP>Mo<SUP>VI</SUP>Fe<SUP>II</SUP></UP> (Eq. 4)

<UP>Mo<SUP>VI</SUP>Fe<SUP>II</SUP></UP> <LIM><OP><ARROW>⇌</ARROW></OP><LL>k<SUB><UP>r</UP></SUB></LL><UL>k<SUB><UP>f</UP></SUB></UL></LIM> <UP>Mo<SUP>V</SUP>Fe<SUP>III</SUP></UP> (Eq. 5)
For a case such as that shown in Fig. 4, in which the photochemically induced reduction of SO occurs much faster than subsequent IET, excellent values for the overall IET rate constant ket (= kf + kr) and parameters a and b can be obtained by fitting the heme re-oxidation phase with the simple exponential function given in Equation 6 (the geometrical meanings of the parameters a and b are shown in Fig. 4A).
A<SUB>555</SUB>=a+b <UP>exp </UP>(<UP>−</UP>k<SUB>et</SUB>t) (Eq. 6)
Based on Equation 5, the parameters a and b in Equation 6 should have the meanings expressed in Equations 7 and 8 (where A0 is simply the absorbance extrapolated to t = 0, assuming that the photochemically induced reduction of SO is instantaneous).
a=A<SUB>0</SUB> <FR><NU>k<SUB>r</SUB></NU><DE>k<SUB>et</SUB></DE></FR>=A<SUB>0</SUB> <FR><NU>k<SUB>r</SUB></NU><DE>k<SUB>f</SUB>+k<SUB>r</SUB></DE></FR> (Eq. 7)

b=A<SUB>0</SUB> <FR><NU>k<SUB>f</SUB></NU><DE>k<SUB>et</SUB></DE></FR>=A<SUB>0</SUB> <FR><NU>k<SUB>f</SUB></NU><DE>k<SUB>f</SUB>+k<SUB>r</SUB></DE></FR> (Eq. 8)

K<SUB><UP>eq</UP></SUB>=<FR><NU>k<SUB>f</SUB></NU><DE>k<SUB>r</SUB></DE></FR>=<FR><NU>b</NU><DE>a</DE></FR> (Eq. 9)
Thus the individual IET rate constants kf and kr can be calculated from ket and Keq (= b/a, Equation 9). The IET rate constants and Keq values for the wild-type human SO (Fig. 4A) and the native chicken SO (Fig. 4B) under the same conditions are shown in Table I.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Transient kinetic trace obtained at 555 nm upon photo-excitation of a solution containing (A) 10.8 µM wild-type human SO or (B) 14.9 µM chicken SO, ~90 µM dRF, and 0.5 mM semicarbazide in 10 mM Tris buffer (pH 7.4). pH was adjusted with HCl. The solid line indicates a single-exponential fit to the IET phase. Keq = b/a.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Flash photolysis kinetic parameters for human and chicken SO
Solutions for flash photolysis experiments contained 0.5 mM semicarbazide, 10 mM Tris. The pH value was adjusted to 7.4 with HCl.

The IET rate constant in wild-type human SO exhibits a linear dependence on the negative 0.6th power of the viscosity (Fig. 5), which is similar to that for chicken SO (-0.7th power, Ref. 30). Control experiments using either sucrose or polyethylene glycol 400 as viscosogen indicate that it is viscosity itself that is responsible for the dependence of IET rates on the solution composition. The viscosity effect suggests that the IET in human SO may also involve significant conformational change, which has been suggested to involve domain rearrangement in the chicken enzyme (30, 37).


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 5.   Fit of viscosity dependence of ket for wild-type human SO in sucrose solution using modified Kramer's theory (30).

The observed rate constant for the initial heme reduction is protein concentration-dependent as expected for a bimolecular process (Equation 4). Electron transfer from dRFH· to the heme of SO can best be observed spectrophotometrically as a decrease in absorbance at 513 nm, which is close to the absorbance maximum for dRFH· and is an isosbestic point for oxidized and reduced heme cofactor. The calculated second order rate constants (k1) for the reduction of wild-type human SO and chicken SO are listed in Table I. As is evident, these are the same within experimental error.

Steady-state Kinetics of Human SO-- The steady-state oxidation of sulfite to sulfate as catalyzed by human SO using cytochrome c as the electron acceptor yields plots of initial velocity versus substrate concentration that display typical saturation kinetics. The kcat values of both wild-type and Y343F were found to vary significantly over the pH range 7.0-9.5 (Fig. 6), and both exhibit bell-shaped pH dependences. Optimum pH values for activities of wild-type and Y343F are ~8.1 and ~8.3, respectively, which are not significantly different. The values of kcat, Kmsulfite and kcat/Kmsulfite around the optimum pH value are shown in Table II.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 6.   The pH dependence of kcat values of wild-type and Y343F human SO. Experiments were performed in 0.1 M buffers (see "Experimental Procedures") between pH 7.0 and 9.5 at 25 °C, with varying concentrations of sulfite and 15 µM cytochrome c.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Steady-state kinetic parameters for wild-type and Y343F human SO
Wild-type is expressed as K108R (Ref. 25).

The Dependence of IET Rates on pH Values-- Fig. 7A shows the dependence of the kf and kr magnitudes of wild-type human SO on [OH-] between pH 7.3 and 8.4, in solutions containing low anion concentrations ([Cl-] ~6.5 mM). Note that both kf and kr decrease significantly as [OH-] increases. The situation is quite different in solutions containing 20 mM Na2SO4 as shown in Fig. 7B in which kf decreases slightly with increasing [OH-], while kr is effectively unchanged. The previously reported inhibition of chicken SO by SO<UP><SUB>4</SUB><SUP>2−</SUP></UP> anions (11) is also observed in the human enzyme as both kf and kr are substantially smaller in Fig. 7B compared with Fig. 7A.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 7.   Dependence of the rate constants kf and kr of wild-type human SO on hydroxide ion concentration. A, 0.5 mM semicarbazide hydrochloride, 6 mM HCl; B, 20 mM Na2SO4, 0.5 mM semicarbazide hydrochloride, 6 mM HCl. For all experiments, the Tris base concentration was chosen so as to achieve the appropriate pH value while keeping [Cl-] between 5 and 6 mM.

We attempted to observe IET in the Y343F mutant in the same pH range as that for the wild-type enzyme. However, no decay subsequent to heme reduction due to IET was observed at 555 nm within this pH range. Even at as low a pH as 6.4, the FeII re-oxidation phase was still not observable and only began to be detectable at pH 6.2. The influence of pH on the IET rate constants of the Y343F mutant were determined between pH 5.8 and 6.2. The SO activities at these low pH values were measured to make certain that the enzyme was still active. It was observed that the mutant remains functional even at pH 5.6 (kcat 1.25 s-1). In addition, the magnitudes of the signal change at 555 nm in flash photolysis experiments were comparable to those observed with the wild-type protein. Fig. 8 shows the effects of pH on Keq for IET in the wild-type and Y343F human SO. Note the shift in the pH range for the mutant compared with the wild-type enzyme. Fig. 9 compares the kinetic traces of the absorbance changes at 555 nm upon laser flash photoexcitation of solutions of Y343F or wild-type human SO at pH 6.0. Note the significant difference in the time scale for these two proteins. Fig. 10 shows the pH dependence of IET rates in the Y343F mutant at low anion concentrations ([Ac-] ~12 mM, [Cl-] ~0.5 mM) between pH 5.8 and 6.2. Due to the slow IET, acetic acid was used to adjust the pH value of the buffer, and experiments on Y343F at high anion concentrations were not conducted at various pH values. The pH profiles of the IET rate constants for the mutant show significant differences from those for wild-type protein (compare Fig. 10 with Fig. 7A). Note that kr for the mutant increases slightly with increasing [OH-], but kf is actually unchanged.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 8.   Effects of pH values on Keq for IET in wild-type and Y343F human SO. The conditions for flash photolysis experiments are the same as shown in the captions of Figs. 7 and 10, respectively.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 9.   Transient kinetic trace obtained at 555 nm upon photo-excitation of a solution containing 12.4 µM Y343F (A) or 9.0 µM wild-type human SO (B), and ~90 µM dRF and 0.5 mM semicarbazide in 20 mM Bis-Tris. pH value was adjusted to 6.0 with HAc. The solid line indicates a single exponential fit to the IET phase.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 10.   Dependence of the rate constants kf and kr of the Y343F mutant on hydroxide ion concentration. Solutions contained 0.5 mM semicarbazide hydrochloride and 20 mM Bis-Tris. Acetic acid was used to adjust the pH value. For all experiments, the free [Ac-] in the solution was 16-18 mM.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

IET Rates of Wild-type Human and Chicken SO-- The observed IET rate constant for the wild-type human SO at pH 7.4 is 491 s-1, which is ~37% of that obtained for chicken SO (1318 s-1) under the same conditions (Fig. 4, Table I). The Keq values for IET in wild-type human SO and chicken SO are 0.73 and 1.63, respectively, which must contribute to the difference in IET rates of these two proteins. Note that the kcat value of wild-type human SO (35 s-1) is also about 50% of that for chicken SO (73 s-1) under standard assay conditions. Taken together, the steady-state kinetic and flash photolysis results are consistent with a recent comprehensive kinetic study of chicken SO (36), which suggests that at pH 7.4 the IET step contributes to the overall kinetic barrier to catalysis. The similarity in the heme reduction rates (k1) of human and chicken SO is consistent with the very high degree (68%) of amino acid sequence homology in human and chicken SO and suggests that the exposure of the heme cofactors in the two proteins is similar.

The pH Dependence of IET Rates in Wild-type Human SO-- In wild-type human SO, at low anion concentrations, both kf and kr decrease significantly with increasing [OH-] (Fig. 7A), which is quite different from the pattern observed previously for chicken SO (10) for which kf decreased but kr remained constant. The reason for this difference is not clear yet. A possible explanation is that the interdomain docking for human SO during the IET reaction may be disfavored upon increasing pH values, making both forward and reverse electron transfer slower.

In the presence of high anion concentrations for wild-type human SO only kf decreases with increasing [OH-], while kr does not change as much (Fig. 7B). However, under comparable conditions, kr for chicken SO increases with increasing [OH-], while kf is effectively unchanged (10), which is remarkably different from wild-type human SO. These differences can be explained by the previously proposed mechanism (10) involving CEPT processes (Scheme 1).

Electron transfer processes in biological systems are often coupled to protonation/deprotonation events, and these effects may influence the kinetics of electron transfer (38). In the case of molybdoenzymes Stiefel has proposed that one-electron transfers are coupled to proton transfers (39). Although this hypothesis is widely accepted and several model systems designed to investigate such processes have been reported (40, 41), only a few studies on CEPT in molybdenum enzymes have been carried out (10, 42).

Scheme 1 can be algebraically expressed by Equations 10 and 11 (derived by a similar procedure to that shown in the supplemental materials for Ref. 10) as follows.
k<SUB>f app</SUB>=<FR><NU>c</NU><DE><UP>d</UP>+[<UP>OH<SUP>−</SUP></UP>]</DE></FR> (Eq. 10)

c=<FR><NU>k<SUB>f(<UP>true</UP>)</SUB>K<SUB>B1</SUB></NU><DE>K<SUB><UP>H<SUB>2</SUB>O</UP></SUB></DE></FR>

d=K<SUB><UP>B1</UP></SUB><FENCE>1+<FR><NU>1</NU><DE>K<SUB><UP>H<SUB>2</SUB>O</UP></SUB></DE></FR>+<FR><NU>[<UP>X<SUP>−</SUP></UP>]</NU><DE>K<SUB><UP>X1</UP></SUB></DE></FR></FENCE>

k<SUB>r <UP>app</UP></SUB>=<FR><NU>k<SUB>r(<UP>true</UP>)</SUB>[<UP>OH<SUP>−</SUP></UP>]</NU><DE><UP>e</UP>+[<UP>OH<SUP>−</SUP></UP>]</DE></FR> (Eq. 11)

e=K<SUB>B2</SUB><FENCE>1+<FR><NU>[<UP>X<SUP>−</SUP></UP>]</NU><DE>K<SUB><UP>X2</UP></SUB></DE></FR></FENCE> (Eq. 12)
In chicken SO, at high anion concentrations, if the parameter d [OH-], the apparent kf is independent of [OH-] (Equation 10); when the parameter e is comparable to [OH-], the apparent kr increases with increasing [OH-] (Equation 11, Ref. 10). Since the parameters d and e are proportional to the dissociation constants KB1 and KB2 (see Scheme 1 for definitions), respectively, it is entirely possible that at sufficiently low values for these two constants, the apparent kf could decrease with increasing [OH-] (when d is comparable to [OH-]), whereas the apparent kr could be independent of [OH-] (when e [OH-]) over the entire pH range investigated as is observed in Fig. 7B. Furthermore, an increase in the association constants KX1 and KX2 may play a similar role according to Equations 10 and 11. Thus, the remarkable difference in the pH dependence of the apparent kf and kr values of human and chicken SO at high anion concentrations may be a consequence of a much stronger binding of anions (X-, OH-) to the active site of human SO than to that of chicken SO, which could be related to differences in the charge distribution around the molybdenum active site in these two proteins.

The pH Dependence of Steady-state Kinetics in Y343F Mutant-- The pH profiles for kcat (Fig. 6) indicate that the mutation in Tyr-343 does not shift the optimum pH value for SO activity, whereas the values of the kinetic constants Kmsulfite and kcat do show an appreciable departure from the equivalent parameters associated with wild-type enzyme. The elevation in Km for sulfite in the Y343F mutant is in accord with a role for Tyr-343 in partially stabilizing the binding of the negatively charged sulfite molecule to the catalytic site (Fig. 1A). The increase in Km combined with the decrease in kcat results in a decrease of nearly 23-fold in the apparent second order rate constant (kcat/Kmsulfite) at pH 8.25 (Table II). Previous detailed kinetic study has shown that the human SO R160Q mutant has a greatly increased Km for sulfite and a marked decrease in kcat resulting in an extreme decrease (1000-fold) in the specificity constant kcat/Kmsulfite (26). The considerable difference in the magnitude of the changes of kcat/Kmsulfite for the Y343F and R160Q mutants can be explained by the different positions of Tyr-343 and Arg-160 in the active site of human SO. In the crystal structure of chicken SO, Tyr-322 (the equivalent of Tyr-343 in human SO) is only weakly hydrogen-bonded to the sulfate anion found in the active site pocket (Tyr-O ··· OSO<UP><SUB>3</SUB><SUP>2−</SUP></UP> = 2.93 Å), whereas the positively charged Arg-138 (the equivalent of Arg-160 in human SO) is directly involved in the attraction of the negatively charged sulfate ion (Arg-O ··· OSO<UP><SUB>3</SUB><SUP>2−</SUP></UP> = 2.63 Å), which is in full accord with the findings reported here.

The pH Dependence of IET Rates in the Y343F Mutant-- The observed significant shift in Keq for the Y343F mutant (Fig. 8) indicates that the mutation in Tyr-343 disfavors the forward IET process (Equation 5), which may be due to the removal of hydrogen-bonding between the equatorial MoV-OH group and the hydroxyl group of Tyr-343 (Fig. 1B). Hydrogen bonding to MoV-OH can stabilize the +5 oxidation-state, thereby making the reduction of MoVI to MoV more favorable. The absence of this hydrogen bonding in the Y343F mutant is expected to decrease Keq substantially (see below). Modulation of reduction potentials by hydrogen bonding is a general phenomenon in biological systems (43, 44). The effect of hydrogen bonding on the reduction potential in molybdenum complexes has been extensively studied (45-48). The NH ··· S hydrogen bond makes a significant contribution to the positive shift of the reduction potential of MoV/MoIV in monooxomolybdenum complexes with o-(acylamino)benzenethiolate ligands (48).

At pH 6.0, the ket value of Y343F is 46 s-1 (compared with 411 s-1 for the wild-type under the same conditions, see Fig. 9). For the mutant, Keq does decrease from 0.36 to 0.24 (Table III). However, such a small shift in Keq (i.e. a thermodynamic factor) cannot account for such a large change in the IET rate constants (~10-fold). The most plausible explanation is that the hydrophobic phenylalanine in the Y343F mutant may hinder direct access of water or H+ to the equatorial Mo=O group (Fig. 1B), thus retarding efficient CEPT (i.e. a kinetic factor). This is clearly shown by the shift in the dependence of Keq for IET to lower pH values in the Y343F mutant (Fig. 8).

                              
View this table:
[in this window]
[in a new window]
 
Table III
Flash photolysis kinetic parameters for wild-type and Y343F human SO at pH 6.0 
Solutions contained 0.5 mM semicarbazide hydrochloride, 20 mM Bis-Tris. The pH value was adjusted to 6.0 with HAc.

For the Y343F mutant at low anion concentrations, kr increases with increasing [OH-], while kf is effectively unchanged (Fig. 10), which is quite different from the wild-type behavior (Fig. 7A). These data can also be explained by the mechanism discussed above for the wild-type enzyme (Scheme 1; Equations 10 and 11). For the sake of brevity, only the analysis for kf app will be presented. For Y343F at the sufficiently high dissociation constant KB1 and low association constant KX1 (making d [OH-]), the apparent value for kf could become pH-independent over the entire pH range investigated, which suggests that the binding of [X-] to the molybdenum active site may not be as effective in the absence of the OH group of Tyr-343. It is reasonable to expect hydrogen-bonding of the hydroxyl of Tyr-343 to anions because of its close proximity to the anion-binding site (Fig. 1A). Thus it is possible that Tyr-343 plays a role in anchoring the anion close to the molybdenum center.

Role of Tyr-343 in the Inhibitory Effect of Sulfate-- At pH 6.0, the ket values of the Y343F mutant without and with 50 mM sulfate are 46 and 2.4 s-1, respectively, while for the wild-type under the same conditions the corresponding ket values are 434 and 7.7 s-1, respectively. The inhibition by SO<UP><SUB>4</SUB><SUP>2−</SUP></UP> anions in the wild-type SO is still apparent in the Y343F mutant, which demonstrates that the OH group of Tyr-343 is not required for sulfate inhibition. Furthermore, the data presented in this paper clearly demonstrate that the OH group of Tyr-343 in human SO plays an important role in IET whether or not anions are bound to the enzyme active site, in contrast to an earlier suggestion that this is only true when sulfate is bound (10).

In conclusion, this study has provided direct evidence for the important role of the conserved active site tyrosine (Tyr-343 in human SO) in transferring protons during the CEPT process and the binding of substrate to the active site. In addition, these results provide experimental rationale for the close proximity of the equivalent tyrosine residue (Tyr-322) to the coordinated ligands of the molybdenum center observed in the crystal structure of chicken SO (4).

    ACKNOWLEDGEMENTS

We thank Dr. Andrew Pacheco and Professor Fraser Armstrong for helpful discussions. We acknowledge the technical assistance of Mr. Ralph Wiley and Ms. Sandra Jaramillo.

    FOOTNOTES

* This work was supported by Grants GM 37773 (to J. H. E.), DK 15057 (to G. T.), and GM 44283 (to K. V. R.) from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed. Fax: 520-621-9288; E-mail: gtollin@u.arizona.edu.

** To whom correspondence should be addressed. Fax: 919-684-8919; E-mail: raj@biochem.duke.edu.

Dagger Dagger To whom correspondence should be addressed. Fax: 520-626-8065; E-mail: jenemark@u.arizona.edu.

Published, JBC Papers in Press, November 11, 2002, DOI 10.1074/jbc.M210374200

    ABBREVIATIONS

The abbreviations used are: SO, sulfite oxidase; IET, intramolecular electron transfer; EPR, electron paramagnetic resonance; dRF, 5-deazariboflavin; dRFH·, 5-deazariboflavin semiquinone; CEPT, coupled electron-proton transfer; ket, observed IET rate constant.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Hille, R. (2002) in Metal Ions in Biological Systems (Sigel, A. , and Sigel, H., eds), Vol. 39 , pp. 187-226, Marcel Dekker, New York
2. Kisker, C. (2001) in Handbook of Metalloproteins (Messerschmidt, A. , Huber, R. , Poulos, T. , and Wieghardt, K., eds), Vol. 2 , pp. 1121-1135, John Wiley & Sons LTD, New York
3. Schindelin, H., Kisker, C., and Rajagopalan, K. V. (2001) Advances in Protein Chemistry , Vol. 58 , pp. 47-94, Academic Press Inc., San Diego
4. Kisker, C., Schindelin, H., Pacheco, A., Wehbi, W., Garret, R. M., Rajagopalan, K. V., Enemark, J. H., and Rees, D. C. (1997) Cell 91, 973-983[Medline] [Order article via Infotrieve]
5. Rajagopalan, K. V. (1980) in Molybdenum and Molybdenum-containing Enzymes (Coughlan, M. P., ed) , pp. 241-272, Pergmon, Oxford, UK
6. Hille, R. (1996) Chem. Rev. 96, 2757-2816[CrossRef][Medline] [Order article via Infotrieve]
7. Speck, S. H., Koppenol, W. H., Dethmers, J. K., Osheroff, N., Morgoliash, E., and Rajagopalan, K. V. (1981) J. Biol. Chem. 256, 7394-7400[Free Full Text]
8. Kessler, D. L., and Rajagopalan, K. V. (1974) Biochim. Biophys. Acta 370, 389-398[Medline] [Order article via Infotrieve]
9. Kessler, D. L., and Rajagopalan, K. V. (1972) J. Biol. Chem. 247, 6566-6573[Abstract/Free Full Text]
10. Pacheco, A., Hazzard, J. T., Tollin, G., and Enemark, J. H. (1999) J. Biol. Inorg. Chem. 4, 390-401[CrossRef][Medline] [Order article via Infotrieve]
11. Sullivan, E. P., Jr., Hazzard, J. T., Tollin, G., and Enemark, J. H. (1993) Biochemistry 32, 12465-12470[Medline] [Order article via Infotrieve]
12. Sullivan, E. P., Jr., Hazzard, J. T., Tollin, G, and Enemark, J. H. (1992) J. Am. Chem. Soc. 114, 9662-9663
13. Astaskin, A. V., Raitsimring, A. M., Feng, C., Johnson, J. L., Rajagopalan, K. V., and Enemark, J. H. (2002) J. Am. Chem. Soc. 124, 6109-6118[CrossRef][Medline] [Order article via Infotrieve]
14. Astashkin, A. V., Raitsimring, A. M., Feng, C., Johnson, J. L., Rajagopalan, K. V., and Enemark, J. H. (2002) Appl. Magn. Reson. 22, 421-430
15. Astashkin, A. V., Mader, M. L., Pacheco, A., Enemark, J. H., and Raitsimring, A. M. (2000) J. Am. Chem. Soc. 122, 5294-5302[CrossRef]
16. Raitsimring, A. M., Pacheco, A., and Enemark, J. H. (1998) J. Am. Chem. Soc. 120, 11263-11278[CrossRef]
17. Pacheco, A., Basu, P., Borbat, P., Raitsimring, A. M., and Enemark, J. H. (1996) Inorg. Chem. 35, 7001-7008[CrossRef][Medline] [Order article via Infotrieve]
18. Enemark, J. H., and Cosper, M. M. (2002) in Metal Ions in Biological Systems (Sigel, A. , and Sigel, H., eds), Vol. 39 , pp. 621-654, Marcel Dekker, New York
19. Eilers, T., Schwarz, G., Brinkmann, H., Witt, C., Richter, T., Nieder, J., Koch, B., Hille, R., Hänsch, R., and Mendel, R. R. (2001) J. Biol. Chem. 276, 46989-46994[Abstract/Free Full Text]
20. Kappler, U., Bennett, B., Rethmeier, J., Schwarz, G., Deutzmann, R., McEwan, A. G., and Dahl, C. (2000) J. Biol. Chem. 275, 13202-13212[Abstract/Free Full Text]
21. Garrett, R. M., Bellissimo, D. B., and Rajagopalan, K. V. (1995) Biochim. Biophys. Acta 1262, 147-149[Medline] [Order article via Infotrieve]
22. Garrett, R. M., and Rajagopalan, K. V. (1994) J. Biol. Chem. 269, 272-276[Abstract/Free Full Text]
23. Neame, P., and Barber, M. J. (1989) J. Biol. Chem. 264, 20894-20901[Abstract/Free Full Text]
24. Temple, C. A., Graf, T. N., and Rajagopalan, K. V. (2000) Arch. Biochem. Biophys. 383, 281-287[CrossRef][Medline] [Order article via Infotrieve]
25. Garrett, R. M., and Rajagopalan, K. V. (1996) J. Biol. Chem. 271, 7387-7391[Abstract/Free Full Text]
26. Garrett, R. M., Johnson, J. L., Graf, T. N., Feigenbaum, A., and Rajagopalan, K. V. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 6394-6398[Abstract/Free Full Text]
27. Leimkuhler, S., and Rajagoplan, K. V. (2001) J. Biol. Chem. 276, 1837-1844[Abstract/Free Full Text]
28. Hille, R. (2000) in Subcellular Biochemistry (Holzenburg, A. , and Scrutton, N. S., eds), Vol. 35 , pp. 445-485, Klumer Academic/Plenum Publisher, New York
29. Johnson, J. L. (1988) Methods Enzymol. 158, 371-382[Medline] [Order article via Infotrieve]
30. Feng, C., Kedia, R. V., Hazzard, J. T., Hurley, J. K., Tollin, G., and Enemark, J. H. (2002) Biochemistry 41, 5816-5821[CrossRef][Medline] [Order article via Infotrieve]
31. Hurley, J. K., Weber-Main, A. M., Stankovich, M. T., Benning, M. M., Thoden, J. B., Vanhooke, J. L., Holden, H. M., Chae, Y. K., Xia, B., Cheng, H., Markley, J. L., Martínez-Júlvez, M., Gómez-Moreno, C., Schmeits, J. L., and Tollin, G. (1997) Biochemistry 36, 11100-11117[CrossRef][Medline] [Order article via Infotrieve]
32. Tollin, G. (2001) in Electron Transfer in Chemistry (Balzani, V., ed), Vol. IV , pp. 202-231, Wiley-VCH, Weinheim, Germany
33. Tollin, G., Hurley, J. K., Hazzard, J. T., and Meyer, T. E. (1993) Biophys. Chem. 48, 259-279[CrossRef][Medline] [Order article via Infotrieve]
34. Tollin, G. (1995) J. Bioenerg. Biomembr. 27, 303-309[Medline] [Order article via Infotrieve]
35. Massey, V. (1959) Biochim. Biophys. Acta 34, 255-256[CrossRef]
36. Brody, M. S., and Hille, R. (1999) Biochemistry 38, 6668-6677[CrossRef][Medline] [Order article via Infotrieve]
37. Elliott, S. J., McElhaney, A. E., Feng, C., Enemark, J. H., and Armstrong, F. A. (2002) J. Am. Chem. Soc. 124, 11612-11613[CrossRef][Medline] [Order article via Infotrieve]
38. Cukier, R. I., and Nocera, D. G. (1998) Annu. Rev. Phys. Chem. 49, 337-369[CrossRef][Medline] [Order article via Infotrieve]
39. Stiefel, E. I. (1973) Proc. Natl. Acad. Sci. U. S. A. 70, 988-992[Abstract]
40. Laughlin, L. J., and Young, C. G. (1996) Inorg. Chem. 35, 1050-1058[CrossRef][Medline] [Order article via Infotrieve]
41. Enemark, J. H., and Young, C. G. (1993) Inorg. Chem. 40, 1-88[CrossRef]
42. Hille, R., and Anderson, R. F. (2001) J. Biol. Chem. 276, 31193-31201[Abstract/Free Full Text]
43. Rotello, V. M. (2001) in Electron Transfer in Chemistry (Balzani, V., ed), Vol. IV , pp. 69-87, Wiley-VCH, Weinheim, Germany
44. Murgida, D. H., and Hildebrandt, P. (2001) J. Am. Chem. Soc. 123, 4062-4068[CrossRef][Medline] [Order article via Infotrieve]
45. Conry, R. E., and Tipton, A. A. (2001) J. Biol. Inorg. Chem. 6, 359-366[CrossRef][Medline] [Order article via Infotrieve].
46. Huang, J., Ostrander, R. L., Rheingold, A. L., Leung, Y., and Walters, M. A. (1994) J. Am. Chem. Soc. 116, 6769-6776
47. Huang, J., Ostrander, R. L., Rheingold, A. L., and Walters, M. A. (1995) Inorg. Chem. 34, 1090-1093
48. Ueyama, N., Okamura, T., and Nakamura, A. (1992) J. Am. Chem. Soc. 114, 8129-8137


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.